The beneficial effect of a calcium channel blocker, Diltiazem, on the ischemic-reperfused heart.
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000503:physiopathology; D003402:Creatine Kinase / Q000378:metabolism; D004110:Diltiazem / Q000494:pharmacology*; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism*; D010477:Perfusion; D051381:Rats
D000227:Adenine Nucleotides; D001552:Benzazepines; D002121:Calcium Channel Blockers; D007473:Ion Channels; D003402:Creatine Kinase; D004110:Diltiazem; D002118:Calcium